Care is advised in the administration of paracetamol to patients with severe renal or severe hepatic impairment. The hazard of overdose is greater in those with non-cirrhotic alcoholic liver disease. Patients who are taking other potentially hepatotoxic drugs are at increased risk of paracetamol-induced hepatotoxicity. Do not exceed the stated dose. Patients should be advised not to take other paracetamol-containing products concurrently. If symptoms persist consult the doctor. If the patient has been diagnosed with liver or kidney impairment seek medical advice. Tablets contain methyl and propyl parabens.
Effects on Ability to Drive and Use Machines: No significant effect.